IUHSA
AERI

Itau Unibanco Holding S.A.’s Aerie Pharmaceuticals AERI Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-626
Closed -$18K – 1008
2019
Q3 		$18K Hold
626
– – ﹤0.01% 266
2019
Q2 		$18K Sell
626
-563
-47% -$21.7K ﹤0.01% 573
2019
Q1 		$42K Hold
1,189
– – ﹤0.01% 540
2018
Q4 		$42K Buy
1,189
+109
+10% +$5.11K ﹤0.01% 540
2018
Q3 		$66K Sell
1,080
-30
-3% -$1.93K ﹤0.01% 533
2018
Q2 		$75K Sell
1,110
-208
-16% -$11.6K 0.01% 580
2018
Q1 		$72K Buy
1,318
+899
+215% +$50.3K ﹤0.01% 456
2017
Q4 		$25K Buy
419
+31
+8% +$1.88K ﹤0.01% 483
2017
Q3 		$60K Sell
388
-990
-72% -$54K ﹤0.01% 565
2017
Q2 		$72K Buy
1,378
+1,244
+928% +$57.9K 0.01% 258
2017
Q1 		$6K Buy
+134
New +$5.98K ﹤0.01% 627

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Itau Unibanco Holding S.A.'s AERI Position: Q4 2019 in Review

Itau Unibanco Holding S.A. sold out of Aerie Pharmaceuticals (AERI) in Q4 2019, closing a stake of 626 shares — an estimated $18K sold.

Itau Unibanco Holding S.A. first reported a position in AERI in Q1 2017 and held it in 11 quarters. The position peaked at $75K in Q2 2018. 167 funds tracked by Wall St. Rank hold AERI as of Q4 2019.

  • Itau Unibanco Holding S.A. reported no remaining Aerie Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 626 Aerie Pharmaceuticals shares in Q4 2019, an estimated $18K.
  • Itau Unibanco Holding S.A. first reported a position in Aerie Pharmaceuticals in Q1 2017 and held it in 11 quarters.
  • Itau Unibanco Holding S.A.'s Aerie Pharmaceuticals position peaked at $75K in Q2 2018.
  • 167 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2019.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2019, filed 14 Feb 2020.